Literature DB >> 8648324

Multifocal motor neuropathy.

E Nobile-Orazio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8648324      PMCID： PMC1073940          DOI： 10.1136/jnnp.60.6.599

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  58 in total

1.  Intravenous immunoglobulin for multifocal motor neuropathy.

Authors:  A G Kermode; B A Laing; W M Carroll; F L Mastaglia
Journal:  Lancet       Date:  1992-10-10       Impact factor: 79.321

2.  Motor neuropathy with multifocal persistent conduction blocks.

Authors:  M Magistris; G Roth
Journal:  Muscle Nerve       Date:  1992-09       Impact factor: 3.217

3.  Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy.

Authors:  R Kaji; H Shibasaki; J Kimura
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

4.  Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera.

Authors:  D Adams; T Kuntzer; D Burger; M Chofflon; M R Magistris; F Regli; A J Steck
Journal:  J Neuroimmunol       Date:  1991-06       Impact factor: 3.478

Review 5.  Manipulating the immune system with immune globulin.

Authors:  J M Dwyer
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

Review 6.  Separating motor neuron diseases from pure motor neuropathies. Multifocal motor neuropathy with persistent conduction block.

Authors:  A J Sumner
Journal:  Adv Neurol       Date:  1991

7.  Immunosuppressive treatment in multifocal motor neuropathy.

Authors:  E L Feldman; M B Bromberg; J W Albers; A Pestronk
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

8.  Pathological findings at the site of conduction block in multifocal motor neuropathy.

Authors:  R Kaji; N Oka; T Tsuji; T Mezaki; T Nishio; I Akiguchi; J Kimura
Journal:  Ann Neurol       Date:  1993-02       Impact factor: 10.422

9.  Experimental conduction block induced by serum from a patient with anti-GM1 antibodies.

Authors:  M Santoro; A Uncini; M Corbo; S M Staugaitis; F P Thomas; A P Hays; N Latov
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

10.  Multifocal motor neuropathy with conduction block: is it a distinct clinical entity?

Authors:  D J Lange; W Trojaborg; N Latov; A P Hays; D S Younger; A Uncini; D M Blake; M Hirano; S M Burns; R E Lovelace
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910
View more
  6 in total

1.  Single fibre electromyography in multifocal motor neuropathy with persistent conduction blocks.

Authors:  A Lagueny; G Le Masson; P Burbeaud; P Deliac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

2.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

3.  Motor-dominant chronic inflammatory demyelinating polyneuropathy.

Authors:  Akio Kimura; Takeo Sakurai; Akihiro Koumura; Megumi Yamada; Yuichi Hayashi; Yuji Tanaka; Isao Hozumi; Hiide Yoshino; Tatsuhiko Yuasa; Takashi Inuzuka
Journal:  J Neurol       Date:  2009-11-22       Impact factor: 4.849

4.  Central motor conduction in patients with anti-ganglioside antibody associated neuropathy syndromes and hyperreflexia.

Authors:  Y Oshima; T Mitsui; H Yoshino; I Endo; M Kunishige; A Asano; T Matsumoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

5.  Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy.

Authors:  N Meucci; A Cappellari; S Barbieri; G Scarlato; E Nobile-Orazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-12       Impact factor: 10.154

6.  Epidemiology and characteristics of Guillain-Barré syndrome in the northwest of Iran.

Authors:  Mohammad Ali Arami; Mohammad Yazdchi; Reza Khandaghi
Journal:  Ann Saudi Med       Date:  2006 Jan-Feb       Impact factor: 1.526
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.